{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T18:48:42Z","timestamp":1769194122795,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:00:00Z","timestamp":1734048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:00:00Z","timestamp":1734048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100006988","name":"John S. Dunn Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006988","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10557-024-07661-2","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T02:09:42Z","timestamp":1734055782000},"page":"1585-1588","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Should We Recommend Vitamin K2 Supplement to Prevent Coronary Artery Calcification for Patients Receiving Statins and\/or Warfarin?"],"prefix":"10.1007","volume":"39","author":[{"given":"Allan Jean","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christie M.","family":"Ballantyne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7653-6328","authenticated-orcid":false,"given":"Yochai","family":"Birnbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,13]]},"reference":[{"issue":"8","key":"7661_CR1","first-page":"927","volume":"5","author":"M Rafieian-Kopaei","year":"2014","unstructured":"Rafieian-Kopaei M, Setorki M, Doudi M, Baradaran A, Nasri H. Atherosclerosis: process, indicators, risk factors and new hopes. Int J Prev Med. 2014;5(8):927\u201346.","journal-title":"Int J Prev Med"},{"issue":"4","key":"7661_CR2","doi-asserted-by":"publisher","first-page":"294","DOI":"10.5551\/jat.RV17020","volume":"25","author":"A Shioi","year":"2018","unstructured":"Shioi A, Ikari Y. Plaque calcification during atherosclerosis progression and regression. J Atheroscler Thromb. 2018;25(4):294\u2013303. https:\/\/doi.org\/10.5551\/jat.RV17020.","journal-title":"J Atheroscler Thromb"},{"issue":"3","key":"7661_CR3","doi-asserted-by":"publisher","first-page":"e009750","DOI":"10.1161\/circimaging.119.009750","volume":"13","author":"JM Smit","year":"2020","unstructured":"Smit JM, van Rosendael AR, El Mahdiui M, et al. Impact of clinical characteristics and statins on coronary plaque progression by serial computed tomography angiography. Circ Cardiovasc Imaging. 2020;13(3):e009750. https:\/\/doi.org\/10.1161\/circimaging.119.009750.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"5","key":"7661_CR4","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1161\/atvbaha.119.313879","volume":"40","author":"HR Alappan","year":"2020","unstructured":"Alappan HR, Kaur G, Manzoor S, Navarrete J, O\u2019Neill WC. Warfarin accelerates medial arterial calcification in humans. Arterioscler Thromb Vasc Biol. 2020;40(5):1413\u20139. https:\/\/doi.org\/10.1161\/atvbaha.119.313879.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"24","key":"7661_CR5","doi-asserted-by":"publisher","first-page":"5121","DOI":"10.1182\/blood-2010-01-264598","volume":"115","author":"RJ Rennenberg","year":"2010","unstructured":"Rennenberg RJ, van Varik BJ, Schurgers LJ, et al. Chronic coumarin treatment is associated with increased extracoronary arterial calcification in humans. Blood. 2010;115(24):5121\u20133. https:\/\/doi.org\/10.1182\/blood-2010-01-264598.","journal-title":"Blood"},{"issue":"6","key":"7661_CR6","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1182\/blood-2018-01-830901","volume":"132","author":"S Wu","year":"2018","unstructured":"Wu S, Chen X, Jin DY, et al. Warfarin and vitamin K epoxide reductase: a molecular accounting for observed inhibition. Blood. 2018;132(6):647\u201357. https:\/\/doi.org\/10.1182\/blood-2018-01-830901.","journal-title":"Blood"},{"key":"7661_CR7","doi-asserted-by":"publisher","unstructured":"Elango K, Javaid A, Khetarpal BK et al. The effects of warfarin and direct oral anticoagulants on systemic vascular calcification: a review. Cells. 2021;10(4). https:\/\/doi.org\/10.3390\/cells10040773.","DOI":"10.3390\/cells10040773"},{"issue":"6","key":"7661_CR8","doi-asserted-by":"publisher","first-page":"635.e1","DOI":"10.1016\/j.amjmed.2015.11.032","volume":"129","author":"TJ Poterucha","year":"2016","unstructured":"Poterucha TJ, Goldhaber SZ. Warfarin and vascular calcification. Am J Med. 2016;129(6):635.e1-4. https:\/\/doi.org\/10.1016\/j.amjmed.2015.11.032.","journal-title":"Am J Med"},{"issue":"3","key":"7661_CR9","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1001\/jama.2013.282535","volume":"311","author":"MH Criqui","year":"2014","unstructured":"Criqui MH, Denenberg JO, Ix JH, et al. Calcium density of coronary artery plaque and risk of incident cardiovascular events. JAMA. 2014;311(3):271\u20138. https:\/\/doi.org\/10.1001\/jama.2013.282535.","journal-title":"JAMA"},{"issue":"4","key":"7661_CR10","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1007\/s00330-023-10229-7","volume":"34","author":"M Marcos-Mangas","year":"2024","unstructured":"Marcos-Mangas M, Revilla-Orodea A, Sevilla T, et al. Different prognostic significance of coronary artery and aortic valve calcium in patients with chest pain. Eur Radiol. 2024;34(4):2658\u201364. https:\/\/doi.org\/10.1007\/s00330-023-10229-7.","journal-title":"Eur Radiol"},{"key":"7661_CR11","doi-asserted-by":"publisher","unstructured":"Han KH, O'Neill WC. Increased peripheral arterial calcification in patients receiving warfarin. J Am Heart Assoc. 2016;5(1). https:\/\/doi.org\/10.1161\/jaha.115.002665.","DOI":"10.1161\/jaha.115.002665"},{"issue":"9","key":"7661_CR12","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.jcmg.2017.04.010","volume":"11","author":"J Andrews","year":"2018","unstructured":"Andrews J, Psaltis PJ, Bayturan O, et al. Warfarin use is associated with progressive coronary arterial calcification: insights from serial intravascular ultrasound. JACC Cardiovasc Imaging. 2018;11(9):1315\u201323. https:\/\/doi.org\/10.1016\/j.jcmg.2017.04.010.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"9","key":"7661_CR13","doi-asserted-by":"publisher","first-page":"322","DOI":"10.31083\/j.rcm2309322","volume":"23","author":"X Wang","year":"2022","unstructured":"Wang X, Peng L, Ma J, Zhang L, Liu J. Warfarin-induced calcification: potential prevention and treatment strategies. Rev Cardiovasc Med. 2022;23(9):322. https:\/\/doi.org\/10.31083\/j.rcm2309322.","journal-title":"Rev Cardiovasc Med"},{"key":"7661_CR14","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.amjcard.2024.08.002","volume":"229","author":"J Ahn","year":"2024","unstructured":"Ahn J, Lee YS, Lee W, et al. Randomized comparison of progression of atherosclerotic plaques and calcification of coronary artery in atrial fibrillation patients treated with edoxaban versus warfarin (The REPRESENT-AF trial). Am J Cardiol. 2024;229:56\u201362. https:\/\/doi.org\/10.1016\/j.amjcard.2024.08.002.","journal-title":"Am J Cardiol"},{"issue":"5","key":"7661_CR15","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1111\/jth.15289","volume":"19","author":"RH van Gorp","year":"2021","unstructured":"van Gorp RH, Dijkgraaf I, Br\u00f6ker V, et al. Off-target effects of oral anticoagulants - vascular effects of vitamin K antagonist and non-vitamin K antagonist oral anticoagulant dabigatran etexilate. J Thromb Haemost. 2021;19(5):1348\u201363. https:\/\/doi.org\/10.1111\/jth.15289.","journal-title":"J Thromb Haemost"},{"key":"7661_CR16","doi-asserted-by":"publisher","first-page":"696244","DOI":"10.3389\/fneur.2021.696244","volume":"12","author":"K Nuotio","year":"2021","unstructured":"Nuotio K, Koskinen SM, M\u00e4kitie L, et al. Warfarin treatment is associated to increased internal carotid artery calcification. Front Neurol. 2021;12:696244. https:\/\/doi.org\/10.3389\/fneur.2021.696244.","journal-title":"Front Neurol"},{"key":"7661_CR17","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.bbacli.2015.08.002","volume":"4","author":"S Namba","year":"2015","unstructured":"Namba S, Yamaoka-Tojo M, Hashikata T, et al. Long-term warfarin therapy and biomarkers for osteoporosis and atherosclerosis. BBA Clin. 2015;4:76\u201380. https:\/\/doi.org\/10.1016\/j.bbacli.2015.08.002.","journal-title":"BBA Clin"},{"key":"7661_CR18","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ahj.2019.02.014","volume":"212","author":"TT Win","year":"2019","unstructured":"Win TT, Nakanishi R, Osawa K, et al. Apixaban versus warfarin in evaluation of progression of atherosclerotic and calcified plaques (prospective randomized trial). Am Heart J. 2019;212:129\u201333. https:\/\/doi.org\/10.1016\/j.ahj.2019.02.014.","journal-title":"Am Heart J"},{"issue":"8","key":"7661_CR19","doi-asserted-by":"publisher","first-page":"e43229","DOI":"10.1371\/journal.pone.0043229","volume":"7","author":"LJ Schurgers","year":"2012","unstructured":"Schurgers LJ, Joosen IA, Laufer EM, et al. Vitamin K-antagonists accelerate atherosclerotic calcification and induce a vulnerable plaque phenotype. PLoS ONE. 2012;7(8):e43229. https:\/\/doi.org\/10.1371\/journal.pone.0043229.","journal-title":"PLoS ONE"},{"issue":"9","key":"7661_CR20","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1111\/jth.15800","volume":"20","author":"S Liu","year":"2022","unstructured":"Liu S, Shen G, Li W. Structural and cellular basis of vitamin K antagonism. J Thromb Haemost. 2022;20(9):1971\u201383. https:\/\/doi.org\/10.1111\/jth.15800.","journal-title":"J Thromb Haemost"},{"issue":"1","key":"7661_CR21","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/fjc.0000000000000008","volume":"63","author":"YT Zhang","year":"2014","unstructured":"Zhang YT, Tang ZY. Research progress of warfarin-associated vascular calcification and its possible therapy. J Cardiovasc Pharmacol. 2014;63(1):76\u201382. https:\/\/doi.org\/10.1097\/fjc.0000000000000008.","journal-title":"J Cardiovasc Pharmacol"},{"key":"7661_CR22","doi-asserted-by":"publisher","unstructured":"Halder M, Petsophonsakul P, Akbulut AC et al. Vitamin K: double bonds beyond coagulation insights into differences between vitamin K1 and K2 in health and disease. Int J Mol Sci. 2019;20(4). https:\/\/doi.org\/10.3390\/ijms20040896.","DOI":"10.3390\/ijms20040896"},{"issue":"1","key":"7661_CR23","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1681\/asn.2019060579","volume":"31","author":"AS De Vriese","year":"2020","unstructured":"De Vriese AS, Caluw\u00e9 R, Pyfferoen L, et al. Multicenter randomized controlled trial of vitamin K antagonist replacement by rivaroxaban with or without vitamin K2 in hemodialysis patients with atrial fibrillation: the Valkyrie Study. J Am Soc Nephrol. 2020;31(1):186\u201396. https:\/\/doi.org\/10.1681\/asn.2019060579.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"7661_CR24","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1053\/j.ajkd.2011.10.041","volume":"59","author":"R Westenfeld","year":"2012","unstructured":"Westenfeld R, Krueger T, Schlieper G, et al. Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial. Am J Kidney Dis. 2012;59(2):186\u201395. https:\/\/doi.org\/10.1053\/j.ajkd.2011.10.041.","journal-title":"Am J Kidney Dis"},{"key":"7661_CR25","doi-asserted-by":"publisher","unstructured":"Vlasschaert C, Goss CJ, Pilkey NG, McKeown S, Holden RM. Vitamin K supplementation for the prevention of cardiovascular disease: where is the evidence? A systematic review of controlled trials. Nutrients. 2020;12(10). https:\/\/doi.org\/10.3390\/nu12102909.","DOI":"10.3390\/nu12102909"},{"issue":"4","key":"7661_CR26","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1093\/nutrit\/nuab061","volume":"80","author":"P Mlad\u011bnka","year":"2022","unstructured":"Mlad\u011bnka P, Mac\u00e1kov\u00e1 K, Kujovsk\u00e1 Kr\u010dmov\u00e1 L, et al. Vitamin K - sources, physiological role, kinetics, deficiency, detection, therapeutic use, and toxicity. Nutr Rev. 2022;80(4):677\u201398. https:\/\/doi.org\/10.1093\/nutrit\/nuab061.","journal-title":"Nutr Rev"},{"key":"7661_CR27","doi-asserted-by":"publisher","unstructured":"Kowara M, Cudnoch-Jedrzejewska A. Pathophysiology of atherosclerotic plaque development-contemporary experience and new directions in research. Int J Mol Sci. 2021;22(7). https:\/\/doi.org\/10.3390\/ijms22073513.","DOI":"10.3390\/ijms22073513"},{"issue":"16","key":"7661_CR28","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1161\/circulationaha.120.050545","volume":"143","author":"AW Peng","year":"2021","unstructured":"Peng AW, Dardari ZA, Blumenthal RS, et al. Very high coronary artery calcium (\u22651000) and association with cardiovascular disease events, non-cardiovascular disease outcomes, and mortality: results from MESA. Circulation. 2021;143(16):1571\u201383. https:\/\/doi.org\/10.1161\/circulationaha.120.050545.","journal-title":"Circulation"},{"issue":"1","key":"7661_CR29","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jcmg.2020.08.036","volume":"14","author":"HY Jin","year":"2021","unstructured":"Jin HY, Weir-McCall JR, Leipsic JA, et al. The relationship between coronary calcification and the natural history of coronary artery disease. JACC Cardiovasc Imaging. 2021;14(1):233\u201342. https:\/\/doi.org\/10.1016\/j.jcmg.2020.08.036.","journal-title":"JACC Cardiovasc Imaging"},{"key":"7661_CR30","doi-asserted-by":"publisher","first-page":"105735","DOI":"10.1016\/j.biocel.2020.105735","volume":"122","author":"L Liberale","year":"2020","unstructured":"Liberale L, Carbone F, Montecucco F, Sahebkar A. Statins reduce vascular inflammation in atherogenesis: a review of underlying molecular mechanisms. Int J Biochem Cell Biol. 2020;122:105735. https:\/\/doi.org\/10.1016\/j.biocel.2020.105735.","journal-title":"Int J Biochem Cell Biol"},{"issue":"6","key":"7661_CR31","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1007\/s00204-023-03492-6","volume":"97","author":"CA German","year":"2023","unstructured":"German CA, Liao JK. Understanding the molecular mechanisms of statin pleiotropic effects. Arch Toxicol. 2023;97(6):1529\u201345. https:\/\/doi.org\/10.1007\/s00204-023-03492-6.","journal-title":"Arch Toxicol"},{"issue":"10","key":"7661_CR32","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1016\/j.jcmg.2018.04.015","volume":"11","author":"SE Lee","year":"2018","unstructured":"Lee SE, Chang HJ, Sung JM, et al. Effects of statins on coronary atherosclerotic plaques: the PARADIGM Study. JACC Cardiovasc Imaging. 2018;11(10):1475\u201384. https:\/\/doi.org\/10.1016\/j.jcmg.2018.04.015.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"3","key":"7661_CR33","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1056\/nejm199007193230302","volume":"323","author":"P Smith","year":"1990","unstructured":"Smith P, Arnesen H, Holme I. The effect of warfarin on mortality and reinfarction after myocardial infarction. N Engl J Med. 1990;323(3):147\u201352. https:\/\/doi.org\/10.1056\/nejm199007193230302.","journal-title":"N Engl J Med"},{"issue":"13","key":"7661_CR34","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1056\/NEJMoa020496","volume":"347","author":"M Hurlen","year":"2002","unstructured":"Hurlen M, Abdelnoor M, Smith P, Erikssen J, Arnesen H. Warfarin, aspirin, or both after myocardial infarction. N Engl J Med. 2002;347(13):969\u201374. https:\/\/doi.org\/10.1056\/NEJMoa020496.","journal-title":"N Engl J Med"},{"issue":"1","key":"7661_CR35","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/cir.0000000000001193","volume":"149","author":"JA Joglar","year":"2024","unstructured":"Joglar JA, Chung MK, Armbruster AL, et al. 2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024;149(1):e1\u2013156. https:\/\/doi.org\/10.1161\/cir.0000000000001193.","journal-title":"Circulation"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-024-07661-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-024-07661-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-024-07661-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T07:00:37Z","timestamp":1766127637000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-024-07661-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,13]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["7661"],"URL":"https:\/\/doi.org\/10.1007\/s10557-024-07661-2","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,13]]},"assertion":[{"value":"4 December 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not relevant for a review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not relevant for a review.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not relevant for a review.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"Allan Jean Zhang: No relevant financial or non-financial interests to disclose.Christie M. Ballantyne: Grant\/research support (through his institution) from Abbott Diagnostic, Akcea, Amgen, Arrowhead, Ionis, Merck, New Amsterdam, Novartis, Novo Nordisk, and Roche Diagnostic for contracted research and consulting fees from 89Bio, Abbott Diagnostics, Amarin, Amgen, Arrowhead, Astra Zeneca, Denka Seiken, Esperion, Genentech, Illumina, Ionis, Eli Lilly, Merck, New Amsterdam, Novartis, Novo Nordisk, and Roche Diagnostic as a consultant.Yochai Birnbaum: No relevant financial or non-financial interests to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}